miR⁃146b⁃5p在高氧诱导的新生大鼠肺血管重塑中的作用:基于铁死亡的调控机制

王薇, 赵婷, 王彦梅, 谢鸥, 王乐

中国当代儿科杂志 ›› 2026, Vol. 28 ›› Issue (7) : 885-892.

PDF(4440 KB)
HTML
PDF(4440 KB)
HTML
中国当代儿科杂志 ›› 2026, Vol. 28 ›› Issue (7) : 885-892. DOI: 10.7499/j.issn.1008-8830.2512010
论著·实验研究

miR⁃146b⁃5p在高氧诱导的新生大鼠肺血管重塑中的作用:基于铁死亡的调控机制

作者信息 +

Role of miR-146b-5p in hyperoxia-induced pulmonary vascular remodeling in neonatal rats: mechanisms based on the regulation of ferroptosis

Author information +
文章历史 +

摘要

目的 探讨miR⁃146b⁃5p在高氧诱导的新生大鼠支气管肺发育不良相关肺动脉高压(bronchopulmonary dysplasia⁃associated pulmonary hypertension, BPD⁃PH)肺血管重塑中的作用及机制。 方法 选取32只Sprague⁃Dawley新生大鼠,随机分为常氧组、BPD⁃PH组、过表达组和抑制剂组,每组8只。常氧组于21%氧浓度环境中饲养,其余3组置于85.0%±0.5%的高氧箱中构建BPD⁃PH模型。其中过表达组经尾静脉注射腺病毒ADV1⁃miR⁃146b⁃5p,抑制剂组注射miR‑146b‑5p抑制剂。建模14 d后,采用共聚焦显微镜观察腺病毒在肺组织中的转染效率;采用直接测压法测定右心室收缩压(right ventricular systolic pressure, RVSP),分离右心室组织称重并计算右心室肥厚指数(right ventricular hypertrophy index, RVHI);苏木精-伊红染色观察肺血管形态并计算血管中膜厚度百分比(medial thickness percentage, MT%)、血管中膜面积百分比(medial area percentage, MA%);透射电子显微镜观察肺血管内皮细胞线粒体的超微结构;3,3'⁃二氨基联苯胺普鲁士蓝染色和亚铁离子试剂盒检测肺组织铁沉积水平;实时荧光定量PCR检测核因子E2相关因子2(nuclear factor erythroid 2⁃related factor 2, Nrf2)、谷胱甘肽过氧化物酶4(glutathione peroxidase 4, GPX4)、溶质载体家族7成员11(solute carrier family 7 member 11, SLC7A11)、长链酰基辅酶A合成酶4(acyl⁃CoA synthetase long⁃chain family member 4, ACSL4)mRNA表达水平,免疫印迹法检测Nrf2、GPX4、SLC7A11、ACSL4蛋白表达水平。 结果 与常氧组比较,BPD⁃PH组新生大鼠RVSP升高,RVHI、MT%、MA%增大,线粒体肿胀,铁沉积增多,Nrf2、GPX4、SLC7A11 mRNA及蛋白表达下调,ACSL4 mRNA及蛋白表达上调(P0.05)。与BPD‑PH组比较,过表达组新生大鼠RVSP升高,RVHI、MT%、MA%增大,线粒体重度肿胀,铁沉积明显增多,Nrf2、GPX4、SLC7A11 mRNA及蛋白表达下调,ACSL4 mRNA及蛋白表达上调(P0.05);抑制剂组RVSP降低,RVHI、MT%、MA%减小,线粒体肿胀缓解,铁沉积减少,Nrf2、GPX4、SLC7A11 mRNA及蛋白表达上调,ACSL4 mRNA及蛋白表达下调(P0.05)。 结论 在高氧暴露下,miR⁃146b⁃5p过表达可促进新生大鼠肺血管重塑,其机制可能与抑制Nrf2/GPX4信号通路、调控铁死亡有关。

Abstract

Objective To investigate the role and mechanism of miR-146b-5p in pulmonary vascular remodeling in neonatal rats with bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH) induced by hyperoxia. Methods Thirty-two Sprague-Dawley neonatal rats were randomly assigned to normoxia group, BPD-PH group, overexpression group, and inhibitor group (n=8 per group). The normoxia group was raised in 21% oxygen, while the other groups were exposed to 85.0%±0.5% hyperoxia to induce BPD-PH. The overexpression group received tail vein injection of ADV1-miR-146b-5p adenovirus; the inhibitor group received miR-146b-5p inhibitor injections. After 14 days, adenovirus transfection efficiency in lung tissue was confirmed by confocal microscopy. Right ventricular systolic pressure (RVSP) was measured by direct manometry. Right ventricular hypertrophy index (RVHI) was calculated by weighing isolated ventricular tissues. Hematoxylin-eosin staining was used to assess pulmonary vascular morphology, and medial thickness percentage (MT%) and medial area percentage (MA%) of pulmonary vessels were calculated. Mitochondrial ultrastructure of pulmonary vascular endothelial cells was observed by transmission electron microscopy (TEM). Iron deposition in lung tissue was detected by DAB Prussian blue staining and ferrous ion colorimetric assay. Quantitative real-time PCR was used to measure mRNA expression levels of nuclear factor erythroid 2-related factor 2 (Nrf2), glutathione peroxidase 4 (GPX4), solute carrier family 7 member 11 (SLC7A11), and acyl-CoA synthetase long-chain family member 4 (ACSL4). Protein expression levels of these molecules were detected by Western blotting. Results Compared with the normoxia group, the BPD-PH group showed significantly increased RVSP, RVHI, MT%, and MA% (P0.05), swollen mitochondria, increased iron deposition, downregulated mRNA and protein expression of Nrf2, GPX4, and SLC7A11, and upregulated expression of ACSL4 (P0.05). Compared with the BPD-PH group, the overexpression group exhibited further increases in RVSP, RVHI, MT%, and MA%, severe mitochondrial swelling, significantly elevated iron deposition, decreased Nrf2, GPX4, and SLC7A11 mRNA and protein levels, and increased ACSL4 expression (P0.05). In contrast, the inhibitor group demonstrated decreased RVSP, RVHI, MT%, and MA%, alleviated mitochondrial swelling, reduced iron deposition, upregulated mRNA and protein levels of Nrf2, GPX4, and SLC7A11, and downregulated mRNA and protein levels of ACSL4 (P0.05). Conclusions Overexpression of miR-146b-5p promotes pulmonary vascular remodeling in neonatal rats exposed to hyperoxia, likely through inhibition of the Nrf2/GPX4 signaling pathway and regulation of ferroptosis.

关键词

支气管肺发育不良相关肺动脉高压 / miR⁃146b⁃5p / 肺血管重塑 / 铁死亡 / 新生大鼠

Key words

Bronchopulmonary dysplasia-associated pulmonary hypertension / miR-146b-5p / Pulmonary vascular remodeling / Ferroptosis / Neonatal rat

引用本文

导出引用
王薇, 赵婷, 王彦梅, . miR⁃146b⁃5p在高氧诱导的新生大鼠肺血管重塑中的作用:基于铁死亡的调控机制[J]. 中国当代儿科杂志. 2026, 28(7): 885-892 https://doi.org/10.7499/j.issn.1008-8830.2512010
Wei WANG, Ting ZHAO, Yan-Mei WANG, et al. Role of miR-146b-5p in hyperoxia-induced pulmonary vascular remodeling in neonatal rats: mechanisms based on the regulation of ferroptosis[J]. Chinese Journal of Contemporary Pediatrics. 2026, 28(7): 885-892 https://doi.org/10.7499/j.issn.1008-8830.2512010

参考文献

[1]
Mascarenhas D, Al-Balushi M, Al-Sabahi A, et al. Pulmonary hypertension in preterm neonates with bronchopulmonary dysplasia: a meta-analysis[J]. Arch Dis Child Fetal Neonatal Ed, 2025, 110(4): 344-352. DOI: 10.1136/archdischild-2024-327547 .
[2]
Li B, Qu SS, Li LX, et al. Risk factors and clinical outcomes of pulmonary hypertension associated with bronchopulmonary dysplasia in extremely premature infants: a systematic review and meta-analysis[J]. Pediatr Pulmonol, 2024, 59(12): 3117-3129. DOI: 10.1002/ppul.27220 .
[3]
王陈红, 陈军津, 葛佳静, 等. 早产儿早期肺动脉高压的危险因素及近期预后[J]. 中华儿科杂志, 2022, 60(7): 682-687. DOI: 10.3760/cma.j.cn112140-20211222-01068 .
[4]
周应祯, 王婷, 付星梦, 等. 支气管肺发育不良的预后[J]. 中国当代儿科杂志, 2025, 27(1): 115-120. PMCID: PMC11750241. DOI: 10.7499/j.issn.1008-8830.2406004 .
[5]
Jia Z, Wang S, Yan H, et al. Pulmonary vascular remodeling in pulmonary hypertension[J]. J Pers Med, 2023, 13(2): 366. PMCID: PMC9967990. DOI: 10.3390/jpm13020366 .
[6]
梁若冰, 朱巧棉, 刘建萍, 等. 早产儿支气管肺发育不良相关肺动脉高压治疗进展[J]. 国际儿科学杂志, 2023, 50(3): 154-158. DOI: 10.3760/cma.j.issn.1673-4408.2023.03.003 .
[7]
Bofill-De Ros X, Vang Ørom UA. Recent progress in miRNA biogenesis and decay[J]. RNA Biol, 2024, 21(1): 1-8. PMCID: PMC10761092. DOI: 10.1080/15476286.2023.2288741 .
[8]
Long Y, Luo Y, Hu L, et al. Targeting miR-146b-5p to regulate KDM6B expression aggravates bronchopulmonary dysplasia[J]. Mol Biotechnol, 2024, 66(8): 2078-2086. DOI: 10.1007/s12033-023-00849-1 .
[9]
Chou HC, Chen CM. Hyperoxia induces ferroptosis and impairs lung development in neonatal mice[J]. Antioxidants (Basel), 2022, 11(4): 641. PMCID: PMC9032171. DOI: 10.3390/antiox11040641 .
[10]
Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease[J]. Nat Rev Mol Cell Biol, 2021, 22(4): 266-282. PMCID: PMC8142022. DOI: 10.1038/s41580-020-00324-8 .
[11]
Luo Y, Zhang Z, Xi S, et al. Bioinformatics analyses and experimental validation of ferroptosis-related genes in bronchopulmonary dysplasia pathogenesis[J]. PLoS One, 2024, 19(6): e0291583. PMCID: PMC11178182. DOI: 10.1371/journal.pone.0291583 .
[12]
Fang C, Tu H, Li R, et al. Bronchopulmonary dysplasia: analysis and validation of ferroptosis-related diagnostic biomarkers and immune cell infiltration features[J]. Pediatr Res, 2024, 96(7): 1673-1680. DOI: 10.1038/s41390-024-03249-6 .
[13]
Zhang F, Liu H. Identification of ferroptosis-associated genes exhibiting altered expression in pulmonary arterial hypertension[J]. Math Biosci Eng, 2021, 18(6): 7619-7630. DOI: 10.3934/mbe.2021377 .
[14]
Li X, Zhang W, Xiao M, et al. MicroRNA-146b-5p protects oligodendrocyte precursor cells from oxygen/glucose deprivation-induced injury through regulating Keap1/Nrf2 signaling via targeting bromodomain-containing protein 4[J]. Biochem Biophys Res Commun, 2019, 513(4): 875-882. DOI: 10.1016/j.bbrc.2019.04.045 .
[15]
Yang M, Chen Y, Huang X, et al. ETS1 ameliorates hyperoxia-induced bronchopulmonary dysplasia in mice by activating Nrf2/HO-1 mediated ferroptosis[J]. Lung, 2023, 201(4): 425-441. PMCID: PMC10444662. DOI: 10.1007/s00408-023-00639-1 .
[16]
谢鸥, 李珊珊, 罗洋, 等. 2-甲氧基雌二醇对新生大鼠缺氧性肺动脉高压的保护作用[J]. 中国当代儿科杂志, 2024, 26(7): 757-764. PMCID: PMC11562046. DOI: 10.7499/j.issn.1008-8830.2401078 .
[17]
谢鸥, 李珊珊, 罗洋, 等. HIF-1α调控TRPC6在新生大鼠HPH肺血管重塑中的作用机制研究[J]. 新疆医科大学学报, 2025, 48(7): 918-923. DOI: 10.3969/j.issn.1009-5551.2025.07.007 .
[18]
Dillon K, Lamba V, Philip RR, et al. Efficacy of sildenafil in infants with bronchopulmonary dysplasia-associated pulmonary hypertension[J]. Children (Basel), 2023, 10(8): 1397. PMCID: PMC10453183. DOI: 10.3390/children10081397 .
[19]
Siddaiah R, Oji-Mmuo C, Aluquin VPR, et al. Multiomics endotyping of preterm infants with bronchopulmonary dysplasia and pulmonary hypertension: a pilot study[J]. Pulm Circ, 2023, 13(2): e12232. PMCID: PMC10142061. DOI: 10.1002/pul2.12232 .
[20]
Song X, Hao X, Zhu BT. Role of mitochondrial reactive oxygen species in chemically-induced ferroptosis[J]. Free Radic Biol Med, 2024, 223: 473-492. DOI: 10.1016/j.freeradbiomed.2024.07.006 .
[21]
Chen D, Yin F, Yang P, et al. TXNIP mediates ferroptosis in a bronchopulmonary dysplasia mouse model by regulating the SLC7A11/GPX4 pathway[J]. Sci Rep, 2025, 15(1): 35188. PMCID: PMC12508065. DOI: 10.1038/s41598-025-19092-6 .
[22]
Ruan Q, Peng Y, Yi X, et al. The tryptophan metabolite 3-hydroxyanthranilic acid alleviates hyperoxia-induced bronchopulmonary dysplasia via inhibiting ferroptosis[J]. Redox Biol, 2025, 82: 103579. PMCID: PMC11981817. DOI: 10.1016/j.redox.2025.103579 .
[23]
Lan J, Chen X, Xu F, et al. Self-assembled miR-134-5p inhibitor nanoparticles ameliorate experimental bronchopulmonary dysplasia (BPD) via suppressing ferroptosis[J]. Mikrochim Acta, 2023, 190(12): 491. PMCID: PMC10687138. DOI: 10.1007/s00604-023-06069-3 .

脚注

所有作者声明不存在利益冲突。

基金

自治区重点研发计划项目(2024B03038-1)
“天山英才”医药卫生高层次人才培养计划(TSYC202401A041)

版权

版权所有 © 2023中国当代儿科杂志
PDF(4440 KB)
HTML

Accesses

Citation

Detail

段落导航
相关文章

/